Sanbio Company Limited Stock Current Ratio
| SNBIF Stock | USD 14.28 0.00 0.00% |
Fundamental analysis of SanBio Company allows traders to better anticipate movements in SanBio Company's stock price by examining its financial health and performance throughout various phases of its business cycle.
SanBio |
SanBio Company Limited OTC Stock Current Ratio Analysis
SanBio Company's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current SanBio Company Current Ratio | 5.45 X |
Most of SanBio Company's fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, SanBio Company Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
| Competition |
In accordance with the recently published financial statements, SanBio Company Limited has a Current Ratio of 5.45 times. This is 87.29% higher than that of the Healthcare sector and 22.14% lower than that of the Biotechnology industry. The current ratio for all United States stocks is 152.31% lower than that of the firm.
SanBio Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses SanBio Company's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of SanBio Company could also be used in its relative valuation, which is a method of valuing SanBio Company by comparing valuation metrics of similar companies.SanBio Company is currently under evaluation in current ratio category among its peers.
SanBio Fundamentals
| Return On Equity | -1.19 | |||
| Return On Asset | -0.74 | |||
| Current Valuation | 306.98 M | |||
| Shares Outstanding | 61.51 M | |||
| Shares Owned By Insiders | 35.76 % | |||
| Shares Owned By Institutions | 4.88 % | |||
| Price To Earning | (31.91) X | |||
| Price To Book | 11.63 X | |||
| Gross Profit | 447 M | |||
| EBITDA | (4.38 B) | |||
| Net Income | (4.68 B) | |||
| Cash And Equivalents | 8.34 B | |||
| Cash Per Share | 139.84 X | |||
| Total Debt | 2.01 B | |||
| Debt To Equity | 0.58 % | |||
| Current Ratio | 5.45 X | |||
| Book Value Per Share | 27.98 X | |||
| Cash Flow From Operations | (6.55 B) | |||
| Earnings Per Share | (0.59) X | |||
| Number Of Employees | 89 | |||
| Beta | 0.25 | |||
| Market Capitalization | 338.28 M | |||
| Total Asset | 5.51 B | |||
| Retained Earnings | (6.67 B) | |||
| Working Capital | 5.91 B | |||
| Current Asset | 6.71 B | |||
| Current Liabilities | 807 M | |||
| Z Score | -0.2 | |||
| Net Asset | 5.51 B |
About SanBio Company Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze SanBio Company Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SanBio Company using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SanBio Company Limited based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| USOI | Credit Suisse X Links | |
| ULTY | Tidal Trust II | |
| CONY | YieldMax N Option | |
| BCAT | BlackRock Capital Allocation | |
| PDI | Pimco Dynamic Income |
Other Information on Investing in SanBio OTC Stock
SanBio Company financial ratios help investors to determine whether SanBio OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in SanBio with respect to the benefits of owning SanBio Company security.